<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
Commission File Number 1-9601
(Check one)
[X] Form 10-K and Form 10-KSB [ ] Form 11-K
[ ] Form 20-F [ ] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For period ended March 31, 1996-------------------------------------------
[ ] Transition Report on Form 10-K and Form 10-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q and Form 10-QSB
[ ] Transition Report on Form N-SAR
For the transition period ended-------------------------------------------
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the item(s) to which the notification relates:-----------------
- -------------------------------------------------------------------------------
PART I
REGISTRANT INFORMATION
K-V PHARMACEUTICAL COMPANY
(Full name of registrant)
2503 SOUTH HANLEY ROAD
(Address of principal executive office)
ST. LOUIS, MISSOURI 63144
(City, State and Zip Code)
<PAGE> 2
PART II
RULE 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check appropriate
box.)
[X] (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report on Form 10-K will be filed
on or before the 15th calendar day following the prescribed due
date or if such date is not a business day during which the
Commission is open for business, the next business day; and
[X] (c) The accountant's statement or other exhibit required
by Rule 12b-25(c) is attached.
PART III
NARRATIVE
The Company is unable to timely file its Annual Report on Form
10-K for the year ended March 31, 1996 because the Company's new
independent auditors, BDO Seidman, LLP, will not complete their
audit of the Company's financial statements for the year ended
March 31, 1996 prior to the expiration of the 90 day period
following the end of the fiscal year during which the Company is
required to file such report under the applicable regulations under
the Securities Exchange Act of 1934, as amended.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard
to this notification.
Gerald R. Mitchell (314) 645-6600
(Name) (Telephone Number)
(2) Have all other periodic reports required under Section 13
or 15(d) or the Securities Exchange Act of 1934 during the
preceding 12 months been filed?
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results
of operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be included in
the subject report or portion thereof?
[X] Yes [ ] No
2
<PAGE> 3
K-V Pharmaceutical Company has caused this notification to be
signed on its behalf by the undersigned thereunto duly authorized.
Date July 1, 1996 By: /s/ Gerald R. Mitchell
----------------------------------------------
Gerald R. Mitchell, Vice President-Finance
3
<PAGE> 4
June 28, 1996
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, D.C. 20549
Gentlemen:
This letter is written in response to the requirement of
Rule 12b-25(c) under the Securities Exchange Act of 1934 and
in satisfaction of item (c) of Part II of Form 12b-25.
We are the independent auditors of KV Pharmaceutical
Company (the "Registrant"). The Registrant has stated in Part
III of its filing on Form 12b-25 that it is unable to timely
file, without unreasonable effort or expense, its Annual
Report on Form 10-K for the year ended March 31, 1996 because
our Firm has not yet completed our audit of the consolidated
financial statements of the Registrant for the year ended
March 31, 1996, and is therefore unable to furnish the
required opinion on such consolidated financial statements.
We hereby advise you that we have read the statements
made by the Registrant in Part III of its filing on Form 12b-
25 and agree with the statements made therein. We are unable
to complete our audit of the Registrant's consolidated
financial statements and furnish the required opinion for a
timely filing because we were not engaged to audit the
consolidated financial statements for the years ended March
31, 1996, 1995 and 1994 until May 24, 1996 and, as a result,
have not yet had sufficient time to complete the auditing
procedures which we consider necessary in the circumstances.
Very truly yours,
/s/ BDO Seidman, LLP
BDO Seidman, LLP
4
